Syntax Advisors, LLC
- SEC CIK
- 0001858294
- Latest filing
- Nov 13, 2023
NKTR holding history
Nektar Therapeutics in every 13F filed by Syntax Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q3 2023 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −26,067−100.0% | Sold out | Holders |
| Q1 2023 | 26,067 | $18.3K | <0.1% | +14,316+121.8% | Added | Holders |
| Q4 2022 | 11,751 | $26.6K | <0.1% | +11,751 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −10,673−100.0% | Sold out | Holders |
| Q2 2022 | 10,673 | $41.0K | <0.1% | +10,673 | New | Holders |